Add BrightSurf on Google Email

Astrocytes help sustain brain activity and blood flow during prolonged sensory stimulation

A research team identified a signaling pathway involving AQP4, TRPA1, BEST1, and D-serine that helps maintain neuronal activity and cerebral blood-volume responses during prolonged sensory stimulation. Astrocytes release D-serine, which supports neuronal activity and contributes to dilation of brain blood vessels.

SourceInstitute for Basic Science·JournalAdvanced Science·TypeExperimental study·DateNov 4, 2026

A lipid "switch" in the bone marrow: how LPC (16:0/0:0) drives immune thrombocytopenia—and how a two-drug combination turns it off

Researchers identified lysophosphatidylcholine (LPC) as a key metabolic mediator of macrophage dysfunction in immune thrombocytopenia. A two-drug combination of dexamethasone and atorvastatin restores immune balance and reverses platelet count recovery.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeExperimental study·DateNov 4, 2026

Heart drug combo reduces kidney damage in septic shock surgery, major trial finds

A new study has found that combining medications dobutamine and norepinephrine during septic shock surgery can significantly lower the risk of acute kidney injury. The trial, which tracked 584 adult patients, showed that the drug combination cut the risk of severe kidney damage in half, reducing moderate to severe kidney injuries.

SourceUniversity of Southampton·JournalJournal of the American Medical Association·TypeRandomized controlled/clinical trial·DateOct 27, 2026

National Academy of Medicine elects St. Jude physician and researcher Carsten Bönnemann, MD, habil., to its membership

Carsten Bönnemann, MD, habil., was elected to the National Academy of Medicine for his research on neuromuscular disorders and his work advancing novel therapeutics. As the inaugural chair of St. Jude's Department of Genomic and Translational Neuroscience, Bönnemann aims to address the unmet need for effective treatments for progressiv...

NCCN highlights collaborations to improve global cancer outcomes during meetings in North America and Asia

NCCN has published regional cancer treatment guidelines for the Philippines, tailored to the local setting and regulatory environment. The guidelines reflect collaborations with global organizations, including the International Gynecologic Cancer Society and the Philippine Society of Medical Oncology, to improve access to high-quality ...

Investment in blood cancer research has saved nearly 26 million years of life, but major gaps in survival remain

Advances in blood cancer treatment have saved 25.8 million life-years, with significant gains for Hodgkin lymphoma and non-Hodgkin lymphoma patients. However, Black patients and those with acute myeloid leukemia (AML) continue to experience worse outcomes, highlighting the need for continued research investment.

SourceAmerican Society of Hematology·JournalBlood Advances·DateSep 1, 2026

Prospective multicenter study of first-line stem cell mobilization with EAP regimen in multiple myeloma and lymphoma

A prospective multicenter study found the EAP regimen delivered outstanding mobilization effects, achieving 90.8% optimal mobilization in patients. The regimen showed good clinical tolerability, with most hematological toxicities well managed, and presented a practical alternative to conventional mobilization strategies.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeCommentary/editorial·DateAug 27, 2026

UT Health San Antonio names NIH expert inaugural director of stem cell transplant and cellular therapy program

Dr. Georg Aue, a nationally recognized blood cancer expert, has been named the inaugural director of the Stem Cell Transplant and Cellular Therapy Program at UT Health San Antonio. The program aims to increase access to new therapeutic approaches for patients across South Texas, with a focus on clinical excellence, research innovation,...

Growth hormone therapy helps childhood stem cell transplant survivors grow taller, but responses vary widely

A Japan-wide study found that growth hormone therapy improves adult height in childhood stem cell transplant survivors with short stature. However, treatment responses were highly variable and influenced by transplant-related factors such as total body irradiation and chronic graft-versus-host disease.

SourceHiroshima University·JournalFrontiers in Endocrinology·TypeData/statistical analysis·DateAug 7, 2026

Researchers find caregivers of children hospitalized for cancer, blood disorders at risk for food insecurity

A study by Wake Forest University School of Medicine found nearly one in five caregivers reported experiencing food insecurity during their child's hospital stay. Children whose caregivers faced food insecurity stayed in the hospital about a third longer on average, with higher rates of readmission within 30 days.

SourceWake Forest University School of Medicine·JournalPediatric Blood & Cancer·TypeSurvey·DateJun 18, 2026

Individuals living with sickle cell disease in sub-Saharan Africa face substantial barriers to managing their condition

Sickle cell disease affects an estimated 7.74 million people worldwide, with sub-Saharan Africa accounting for two-thirds of global cases. Individuals living in this region are less likely to use medications or go to the hospital for pain crises, relying more on homeopathic remedies and delaying medical care.

SourceAmerican Society of Hematology·JournalBlood Global Hematology·DateApr 14, 2026

ASH and ISTH publish new clinical practice guidelines on anticoagulant prophylaxis in pediatric patients at risk of blood clots

The American Society of Hematology and the International Society on Thrombosis and Haemostasis have released comprehensive guidelines for anticoagulant prophylaxis in non-cardiac pediatric patients at risk of venous thromboembolism. The guidelines outline best practices for preventing life-threatening complications in children.

SourceAmerican Society of Hematology·JournalBlood Advances·DateApr 8, 2026

Researchers create an injectable particle to make surgery safer for infants

A team of researchers at North Carolina State University has created an injectable microgel called B-knob triggered microgels (BK-TriGs) that can help reduce bleeding in infants during surgery. The microgel works by mimicking the mechanical properties of natural platelets, which helps to create fibrin networks and stanch bleeding.

SourceNorth Carolina State University·JournalScience Advances·TypeExperimental study·DateApr 3, 2026

ASH publishes clinical practice guidelines on diagnosis and management of severe and very severe acquired aplastic anemia

The American Society of Hematology has published clinical practice guidelines for diagnosing and managing severe acquired aplastic anemia, a rare and life-threatening bone marrow failure disorder. The guidelines highlight the importance of shared decision-making between patients and providers, as well as the need for additional researc...

SourceAmerican Society of Hematology·JournalBlood Advances·DateApr 1, 2026

Phase 3 study: New therapy keeps gastrointestinal cancer care on course when low platelets are an obstacle

A phase 3 clinical trial found romiplostim significantly reduced chemotherapy dose delays and improved platelet counts in patients with gastrointestinal cancers who developed persistent low platelet counts during treatment. The therapy enables patients to maintain chemotherapy intensity, potentially preserving the integrity of cancer c...

SourceUniversity of Miami Miller School of Medicine·JournalNew England Journal of Medicine·DateMar 16, 2026

Hidden genetic mismatch, which triples the risk of a life-threatening immune attack after cord blood transplantation

A large registry study identifies a specific genetic mismatch linked to severe acute graft-versus-host disease (aGVHD) after cord blood transplantation, tripling the risk of life-threatening complications. Researchers found that a particular HLA combination in donors and recipients increased aGVHD risk by threefold.

SourceFujita Health University·JournalTransplantation and Cellular Therapy·TypeObservational study·DateFeb 20, 2026

Periods may trigger pain for many who have sickle cell disease

A nationwide study found that periods can trigger severe pain in many women and girls with sickle cell disease, leading to emergency department visits and hospitalizations. The study's authors recommend a routine menstrual history screening as part of annual sickle cell care and connecting patients with reproductive health specialists.

SourceUniversity of California - San Francisco·JournalJAMA Network Open·TypeSurvey·DateFeb 19, 2026

ASH publishes clinical practice guidelines on frontline and relapsed/refractory management of all in adolescents and young adults

The American Society of Hematology released guidelines for frontline and relapsed/refractory management of acute lymphoblastic leukemia (ALL) in adolescents and young adults (AYAs), outlining optimal approaches to treating high-risk patient populations. The guidelines highlight the need for additional research on immunotherapies and tr...

SourceAmerican Society of Hematology·JournalBlood Advances·DateFeb 11, 2026

An open source breakthrough in hemodynamics

Researchers have developed an open-source pressure myography tool, HemoLens, which reduces the cost of vascular research to $750 from $40,000. The tool uses affordable manufacturing processes and customizable components, making it easier for researchers to study vascular function.

SourceUniversity of Pittsburgh·JournalDevice·TypeExperimental study·DateFeb 2, 2026

Blood test detects lingering lung damage after COVID 19

A study published in EBioMedicine found changes in blood samples from almost 1,000 people hospitalized for COVID-19 may pinpoint patients at risk of long-term lung disease. The study identified elevated levels of certain molecules, which could lead to the development of simple blood tests to detect ongoing lung problems.

SourceUniversity of Leicester·JournalEBioMedicine·TypeObservational study·DateJan 27, 2026

Chromatin accessibility maps reveal how stem cells drive myelodysplastic progression

Chromatin accessibility maps reveal that MDS stem cells gradually lose their normal identity and acquire characteristics typical of myeloid progenitors. A 'progenitor score' developed by the team tracks cell movement toward a progenitor-like state, correlating with disease severity and prognosis.

SourceThe Institute of Medical Science, The University of Tokyo·JournalNature Communications·TypeData/statistical analysis·DateDec 12, 2025

NEJM Group launches NEJM Clinician

NEJM Clinician curates highly relevant clinical insights from over 150 peer-reviewed journals to give physicians clear guidance without the noise. The weekly publication delivers summaries and commentary in a concise, 30-minute read, helping healthcare providers stay informed and confident in their decisions.

SourceNEJM Group·JournalNew England Journal of Medicine·DateDec 8, 2025

ASH 2025: Safety and efficacy data from a phase 1 study show promise of next-generation CAR-T cell therapy in patients with refractory B-cell acute lymphoblastic leukemia

Researchers present phase 1 study results of rapcabtagene autoleucel, a rapid CAR-T cell manufacturing platform that reduced production time to under two days. The treatment showed a manageable safety profile and promising antitumor activity, with complete remission rates ranging from 70% to 100% in patients.